Author

Jean-Luc Van-Laethem

Université Libre de Bruxelles

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:clustering· 1 Research Focus:differential expression· 1 Organism:human· 1 Approach:statistical model· 1

Frequent Co-Authors

Akeila BellahcèneiD· 1 shared Christelle BouchartiD· 1 shared Jawad Tarfouss· 1 shared Jerome F. CrosiD· 1 shared Joel Rodrigues VitóriaiD· 1 shared Julie NaveziD· 1 shared Kosta StosiciD· 1 shared Laurine VersetiD· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Akeila BellahcèneORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Cancer BiologybioRxivPreprintJul 7, 2025

Glycation Stress-Driven Transcriptomic Signature Predicts Survival Benefit from Adjuvant Gemcitabine in Resectable Pancreatic Cancer.

Oier Azurmendi Senar, Kosta Stosic, Christelle Bouchart…·Jean-Luc Van-Laethem

The paper develops a 16-gene signature (MG-GEM) that predicts survival benefit from adjuvant gemcitabine in resectable pancreatic cancer based on glycation stress, outperforming existing signatures.

DOI 10.1101/2025.07.07.663493

humanbulk RNA-seq

𝕏 PostBluesky